Almirall SA ADR ALMRY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $14.29
- Day Range
- $10.53–10.53
- 52-Week Range
- $10.53–15.56
- Bid/Ask
- $10.08 / $13.99
- Shares Outstanding
- 217.61M
- Market Cap
- $2.26B
- Volume/Avg
- 2,190 / 1,133
Key Statistics
- Price/Earnings (Normalized)
- 44.36
- Price/Sales
- 1.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,097
- Website
- http://www.almirall.es
Valuation
|
Metric
|
ALMRY
|
|---|---|
Price/Earnings (Normalized) | 44.36 |
Price/Book Value | 1.70 |
Price/Sales | 1.78 |
Price/Cash Flow | 11.71 |
Price/Earnings
ALMRY
Financial Strength
|
Metric
|
ALMRY
|
|---|---|
Quick Ratio | 1.70 |
Current Ratio | 2.31 |
Interest Coverage | 6.11 |
Quick Ratio
ALMRY
Profitability
|
Metric
|
ALMRY
|
|---|---|
Return on Assets (Normalized) | 3.13% |
Return on Equity (Normalized) | 4.90% |
Return on Invested Capital (Normalized) | 4.47% |
Return on Assets
ALMRY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Sq!R>Y!f | LOCK|?>>P | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|!v#Ww^W | LOCK|@!%&G | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|#Xmf<$V | LOCK|gw< | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|@%#>zzM | LOCK|!%Y | $33B | |||
| Viatris Inc
VTRS
| LOCK|V!r!<P< | LOCK|!g | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|@@ | LOCK|fwY | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|CN##<@R | LOCK|#cX | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|#<k@<hL | LOCK|v<R | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|?@LPWpX | LOCK|jD#Z? | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|wPHp!zZ | LOCK|#W> | $2B |
United States